THE ASSOCIATION BETWEEN THE DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS AND THE INTIMA-MEDIA THICKNESS OF THE CAROTID ARTERY

Tuấn Nguyễn Châu, Ngọc Cao Thanh, Thụy Trần Hồng, Sơn Đặng Ngọc

Main Article Content

Abstract

Introduction: Rheumatoid arthritis (RA) increases the risk of cardiovascular diseases and cardiovascular-related mortality. RA has been shown to increase the likelihood of forming carotid artery atherosclerotic plaques and is associated with the intima-media thickness of the carotid artery (CIMT). However, the relationship between disease activity in RA and carotid artery IMT remains unclear. Subjects and Methods: This cross-sectional study was conducted on 65 RA patients at the University of Medicine and Pharmacy Hospital, Ho Chi Minh City. Patients were diagnosed with RA based on the ACR/EULAR 2010 classification criteria. Carotid artery ultrasound was performed to assess atherosclerotic plaques and CIMT. The study recorded clinical and subclinical characteristics of RA, disease activity assessed by DAS28, CDAI, and SDAI scores, and the characteristics of the CIMT. Linear regression analysis was used to examine the relationship between these factors and CIMT. Results: The 65 RA patients had an average age of 67 years, with females making up 55 out of 65 patients. 96.92% of patients were seropositive, and the average disease duration was 3 years. No significant statistical difference was found between disease activity and the formation of atherosclerotic plaques or CIMT. Age (r = 0.454, p < 0.001) and disease duration (r = 0.561, p < 0.001) were correlated with CIMT, while no correlation was observed between disease activity and CIMT. Conclusion: RA disease activity is not associated with CIMT. Age and disease duration are more strongly associated with CIMT and serve as prognostic factors in evaluating RA patients.

Article Details

References

1. Gravallese EM, Firestein GS. Rheumatoid arthritis—common origins, divergent mechanisms. New England Journal of Medicine. 2023; 388(6):529-542.
2. Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular disease risk in rheumatoid arthritis anno 2022. Journal of clinical medicine. 2022;11(10):2704.
3. Hansildaar R, Vedder D, Baniaamam M, Tausche A-K, Gerritsen M, Nurmohamed MT. Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. The Lancet Rheumatology. 2021;3(1):e58-e70.
4. England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. Bmj. 2018;361
5. Rojas-Giménez M, López-Medina C, Ladehesa-Pineda ML, et al. Subclinical atherosclerosis measure by carotid ultrasound and inflammatory activity in patients with rheumatoid arthritis and spondylarthritis. Journal of Clinical Medicine. 2022;11(3):662.
6. Suad H, Haifa H, Fahda A, Al Salmi I. Subclinical atherosclerosis in rheumatoid arthritis patients of the Gulf Cooperated Council. Saudi Medical Journal. 2020;41(9):1022-1025.
7. Ozisler C, Ates A, Karaaslan Y, et al. Clinical significance of aortic stiffness, carotid intima-media thickness and serum osteoprotegerin level in rheumatoid arthritis patients. The Egyptian Rheumatologist. 2019;41(2):111-115.
8. Semb AG, Rollefstad S, Provan SA, et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. The Journal of rheumatology. 2013;40(4):359-368.
9. Initiative C. 2010 rheumatoid arthritis classification criteria. Arthritis & Rheumatism. 2010;62(9):2569-2581.
10. Khaliq T, Shan S, Shah SA, Saleem S, Adil MH. Carotid intimomedial thickness (CIMT) in patients with rheumatoid arthritis; the need for more aggressive cardiovascular screening in RA. J Coll Physicians Surg Pak. 2023;33:427-32.